STM Article Repository

Trieu, Nguyen Thi and Duc, Tran Minh and Tu, Tran Minh Cam (2022) Treatment of Uterine Fibroid in Pregnancy. B P International, pp. 27-46. ISBN 978-81-960551-8-9

Full text not available from this repository.

Abstract

Develop a treatment to help pregnant women carry and give birth normally when there is multiple fibroids in the uterine muscles. Uterine fibroids are very common and can be detected during the pregnancy of reproductive-age women. Uterine fibroids usually grow very quickly in the first 3 months of pregnancy.

Clinically it shows that:

Uterine fibroids are associated with abundant and prolonged menstruati
The woman's ability to get pregnant and give birth is fraught with difficultie Fibroids increase the rate of spontaneous abortion, premature birth, placental abruption, labor disorders, cesarean section, and postpartum hemorrhage due to poor uterine contraction. Pain is the most common complication of uterine fibroids during pregnancy.
The problem is finding a way to make the fibroids stop growing and degenerate, to create safety for the fet There will be many complications for pregnant women and fetuses if not managed and intervened early. The selected drugs have anti-tumor effects without side effects detected, which can cause fibroids to soften and lie evenly in the uterine muscles. The fact that the ingredients act well in the process of fibroid degeneration, protecting pregnant women and the fetus has proven to be successful in the treatment of uterine fibroids during pregnancy. The fetus will adjust itself well in the uterine cavity, not being occupied by fast-growing tumors encroaching on the uterine cavity.
Fibroids will stop growing and disappear during pregnancy if pregnenolone and Coenzyme Pyridoxal Phosphate are used for early interventi The course of treatment helps the fetus to develop normally. These women will have a normally developing uterus through the stages of pregnancy. Their uterus is egg-shaped, the uterine muscles are only a few millimeters thicker than normal uterine muscles, and the placenta adheres tightly to the lining of the uterus with adequate perfusion like other normal pregnancies.
Calculate a sufficient amount of Pregnenolone and Coenzyme Pyridoxal Phosphate to apply to the degeneration of fibroi These components will soften uterine fibroids and remove the bulk-forming texture. Pregnenolone is produced in the adrenal glands and central nervous system. Pregnenolone is synthesized from Cholesterol and it is a precursor of Progesterone, Estrogen and dehydroepiandrosterone (DHEA). In some people, Pregnenolone will gradually decrease with age leading to an imbalance between Progesterone, Estrogen. According to studies, this imbalance is responsible for the abnormal growth and shaping of the connective tissue of uterine muscle fiber cells, creating uterine fibroids. Pregnenolone supplements are necessary for reproductive age women and pregnant women with uterine fibroids because fibroids will grow rapidly, occupied the fetuses' space. There will be many problems that need to be intervened during pregnancy and during childbirth, with the risk of miscarriage or premature birth.
Pregnenolone, and Coenzyme Pyridoxal Phosphate are included in the composition used to treat uterine fibroids during pregnancy. They help to balance the metabolism of steroid hormones. The composition present in the body will inhibit the abnormal growth of the structure of uterine muscle fibers, soften the muscle fibers and connective tissue in the fibroid tumor, return to its normal structure, merge into the uterine muscles. The uterus returns to its normal state. The fetus will develop naturally until the pregnancy reaches full term.

Item Type: Book
Subjects: GO for ARCHIVE > Medical Science
Depositing User: Unnamed user with email support@goforarchive.com
Date Deposited: 04 Oct 2023 05:20
Last Modified: 04 Oct 2023 05:20
URI: http://eprints.go4mailburst.com/id/eprint/1254

Actions (login required)

View Item
View Item